![Cells | Free Full-Text | Targeting the CD40-CD154 Signaling Pathway for Treatment of Autoimmune Arthritis Cells | Free Full-Text | Targeting the CD40-CD154 Signaling Pathway for Treatment of Autoimmune Arthritis](https://pub.mdpi-res.com/cells/cells-08-00927/article_deploy/html/images/cells-08-00927-g001.png?1566928406)
Cells | Free Full-Text | Targeting the CD40-CD154 Signaling Pathway for Treatment of Autoimmune Arthritis
![IJMS | Free Full-Text | CD40/CD40L and Related Signaling Pathways in Cardiovascular Health and Disease—The Pros and Cons for Cardioprotection IJMS | Free Full-Text | CD40/CD40L and Related Signaling Pathways in Cardiovascular Health and Disease—The Pros and Cons for Cardioprotection](https://pub.mdpi-res.com/ijms/ijms-21-08533/article_deploy/html/images/ijms-21-08533-ag.png?1607087365)
IJMS | Free Full-Text | CD40/CD40L and Related Signaling Pathways in Cardiovascular Health and Disease—The Pros and Cons for Cardioprotection
![Nanoimmunotherapy targeting CD40–TRAF6 signalling to reduce atherosclerosis | Nature Reviews Cardiology Nanoimmunotherapy targeting CD40–TRAF6 signalling to reduce atherosclerosis | Nature Reviews Cardiology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41569-018-0024-x/MediaObjects/41569_2018_24_Figa_HTML.jpg)
Nanoimmunotherapy targeting CD40–TRAF6 signalling to reduce atherosclerosis | Nature Reviews Cardiology
![CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies | Cellular & Molecular Immunology CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies | Cellular & Molecular Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41423-021-00734-4/MediaObjects/41423_2021_734_Fig1_HTML.png)
CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies | Cellular & Molecular Immunology
![CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response - ScienceDirect CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1535610819301011-fx1.jpg)